BioSpace News Archive

Business

RenaSci bolsters kidney disease and fibrosis capabilities with senior appointment

Leading in vivo pharmacology and consultancy services firm RenaSci, part of the Sygnature Group, have bolstered their Kidney Disease and Fibrosis capabilities with the appointment of Dr Wioletta Pijacka.

January 9, 2020
·
3 min read
SOTIO Opens Office in Basel, Switzerland, to Accelerate Development of its Pipeline Products

SOTIO, a biotechnology company owned by the PPF Group, announce today the opening of offices of SOTIO Biotech AG at the Technology Park Basel, Switzerland.

January 9, 2020
·
5 min read
Deals

Mesa Labs Declares Quarterly Dividend payable on March 16, 2020

Mesa Laboratories, Inc. announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.

January 9, 2020
·
2 min read
Drug Development

AzurRx BioPharma To Present Interim Phase 2 Clinical Study Data for MS1819-SD at Biotech Showcase 2020 Conference (January 13) in San Francisco

Initial data from the first five patients indicate positive trends for all primary and secondary safety and efficacy endpoints in AzurRx’s Phase 2 Clinical Study for MS1819-SD, in combination with standard PERT for Cystic Fibrosis patients with severe exocrine pancreatic insufficiency.

January 9, 2020
·
5 min read
Business

ResMed to Report Second Quarter Fiscal 2020 Earnings on January 30, 2020

ResMed announced it plans to release financial and operational results for the second quarter of fiscal year 2020 on Thursday, January 30, 2020, after the New York Stock Exchange closes.

January 9, 2020
·
1 min read
Business

Portola Announces Preliminary Full Year 2019 Andexxa Global Net Revenues of Approximately $111 Million

Fourth Quarter Net Revenues of Andexxa Expected to be Approximately $28 Million Including $4 Million in Fourth Quarter Sales from Ondexxya in Europe

January 9, 2020
·
9 min read
Deals

AVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Jan. 9, 2020

AVROBIO announced that the Company has granted a non-statutory stock option to a new employee as an inducement award under the Company’s 2019 Inducement Plan, in accordance with NASDAQ Listing Rule 5635.

January 9, 2020
·
1 min read
Business

Waters Corporation Q4 2019 Financial Results Webcast Invitation

A replay of the webcast will be available until February 11th at midnight eastern time.

January 9, 2020
·
1 min read
Business

BD Announces Live Webcast Of First Fiscal Quarter 2020 Earnings Conference Call

BD announced that it will conduct a live webcast of its first fiscal quarter 2020 earnings conference call on Thursday, February 6, 2020, at 8:00 a.m.

January 9, 2020
·
1 min read
Business

Cryoport Announces Preliminary Fourth Quarter and Full Year 2019 Revenue

2019 Revenue Grows 73%, BioPharma Revenue Grows 64%

January 9, 2020
·
4 min read